BICO Group

18.95 SEK

-4.68 %

Less than 1K followers

BICO

NASDAQ Stockholm

Medical Equipment & Services

Health Care

Overview

Financials & Estimates

Ownership

Investor consensus

-4.68 %

-9.42 %

-22.14 %

-48.64 %

-40.82 %

-40.89 %

-73.10 %

-90.55 %

+39.08 %

BICO Group operates in the biotechnology industry and focuses on the development and manufacturing of technologies for cell-based research and medical development. The company's products are aimed at researchers and pharmaceutical companies. The business is global with a main presence in Europe, North America and Asia. BICO Group was founded in 2016 and is headquartered in Gothenburg, Sweden.

Market cap

1.34B SEK

Turnover

3.16M SEK

Revenue

1.95B

EBIT %

-14.85 %

P/E

-

Dividend yield-%

-

Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar

18.2

2026

Annual report '25

29.4

2026

Interim report Q1'26

7.5

2026

General meeting '26

All

Webcasts

Press releases

ShowingAll content types

Press release11/14/2025, 11:34 AM

Redeye: BICO (Q3 Review) - A return to organic growth and adjusted EBITDA profitability

BICO, Audiocast, Q3'25

Webcast11/4/2025, 9:00 AM

BICO, Audiocast, Q3'25

Regulatory press release11/4/2025, 6:00 AM

Publication of BICO Group AB: Interim report Q3 2025

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account

Followings and notifications on followed companies

Analyst comments and recommendations

Stock comparison tool & other popular tools

Regulatory press release11/3/2025, 5:01 PM

BICO provides preliminary figures for Q3 2025 and announces impairment

Press release10/21/2025, 5:00 AM

Invitation to the presentation of BICO’s Interim report Q3 2025

Regulatory press release10/10/2025, 5:00 AM

BICO Group AB’s Nomination Committee for the 2026 Annual General Meeting

Regulatory press release9/16/2025, 4:28 PM

Maria Rankka appointed Board Chair of BICO Group AB

Press release9/15/2025, 5:00 AM

Fraser McLeod appointed as Managing Director of BICO company Biosero

Regulatory press release9/4/2025, 10:05 PM

BICO company Biosero to develop integrated lab automation solutions to a value of 15.2 MUSD

Press release8/28/2025, 8:34 AM

Redeye: Redeye Initiates Coverage of BICO Group

BICO, Audiocast, Q2'25

Webcast8/19/2025, 8:00 AM

BICO, Audiocast, Q2'25

Regulatory press release8/19/2025, 5:00 AM

Publication of BICO Group AB Interim report January-June 2025

Press release8/18/2025, 4:00 PM

BICO Group AB (publ) has repurchased convertible bonds to a total nominal amount of SEK 98m

Press release8/5/2025, 5:00 AM

Invitation to the presentation of BICO’s Interim report Q2 2025

Press release7/1/2025, 3:30 PM

BICO has completed the divestment of MatTek and Visikol

Regulatory press release6/25/2025, 5:00 AM

Lars Risberg appointed as General Counsel for BICO Group AB

Regulatory press release5/23/2025, 5:00 AM

Chief Operating Officer Marius Balger is leaving BICO

Regulatory press release5/8/2025, 4:15 PM

Bulletin from Annual General Meeting in BICO Group AB (publ)

BICO, Audiocast with teleconference, Q1'25

Webcast4/29/2025, 8:00 AM

BICO, Audiocast with teleconference, Q1'25

Regulatory press release4/29/2025, 5:00 AM

Publication of BICO Group AB Interim report Q1 2025

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.